Over the last 12 months, Hims & Hers Health insiders reported 1 buy totaling $1.2M and 7 sales totaling $3.7M across SEC Form 4 filings. 88% of the activity was filed under pre-arranged 10b5-1 trading plans.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 17, 2026 | Okupe OluyemiChief Financial Officer · O | ▼ Sale | 7,163 | $31.99 | $229K | -2.5% | plan |
| Jul 6, 2026 | Okupe OluyemiChief Financial Officer · O | ▼ Sale | 7,163 | $36.49 | $261K | -2.5% | plan |
| Jun 22, 2026 | Okupe OluyemiChief Financial Officer · O | ▼ Sale | 18,197 | $34.03 | $619K | -6% | plan |
| Jun 18, 2026 | Carroll Patrick HarrisonChief Medical Officer · O | ▼ Sale | 23,726 | $35 | $830K | -11.5% | plan |
| Jun 17, 2026 | Chi MichaelChief Operating Officer · O | ▼ Sale | 14,027 | $31.5 | $442K | -3.1% | plan |
| Jun 17, 2026 | Becklund IrenePAO · O | ▼ Sale | 12,063 | $30.72 | $371K | -64% | plan · 2 tranches |
| Jun 17, 2026 | Elshenawy MohamedCTO · O | ▼ Sale | 30,040 | $31.5 | $946K | -22.9% | plan |
| May 26, 2026 | WELLS DAVID BD | ▲ Buy | 48,400 | $24.24 | $1.2M | +27.5% | — |
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $HIMS feed.